Acadian Asset Management LLC Xeris Biopharma Holdings, Inc. Transaction History
Acadian Asset Management LLC
- $57.3 Billion
- Q3 2025
A detailed history of Acadian Asset Management LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 921,103 shares of XERS stock, worth $6.68 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
921,103
Previous 383,237
140.35%
Holding current value
$6.68 Million
Previous $1.79 Million
319.01%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
237Shares Held
94.4MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...